NCT07499830

Brief Summary

This research aims to evaluate a comprehensive AI-driven workflow for both clinical data extraction and diagnostic classification in coronary artery disease (CAD). Leveraging OCR and Large Language Models (LLMs), the system is designed to extract ten key clinical parameters (such as LVEF and lab results) and provide diagnostic subtypes (UA, STEMI, NSTEMI, CCS) directly from unstructured inpatient records. A man-machine comparative trial will be conducted using a test set of 308 patients, where the performance of the LLM-based workflow will be benchmarked against the average diagnostic accuracy and processing time of seven clinical physicians. The findings will provide evidence for the feasibility of using LLMs to enhance clinical data structuring and diagnostic efficiency in cardiology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2026

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2026

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

February 1, 2026

Enrollment Period

6 days

First QC Date

March 24, 2026

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Overall Diagnostic and Extraction Accuracy Rate

    To calculate the overall accuracy rate of the LLM-based workflow across 308 cases (including the pilot set, internal validation cohort, and external validation cohort) for 10 clinical indicators (e.g., LVEF, blood glucose, etc.) and 4 diagnostic subtypes of coronary artery disease. Accuracy is defined as the proportion of cases where the LLM's extraction or diagnostic results are perfectly consistent with the 'Gold Standard' established by human clinical experts.

    Through study completion, an average of 3 months.

Study Arms (3)

Test Cohort

This group consists of 50 patient records from the AIM-CHD Study at Fuwai Hospital. These data are specifically utilized for refining OCR processing and optimizing Prompt Engineering for the LLM-based workflow.

Device: OCR-Prompt-LLM Information Extraction WorkflowDevice: Manual Clinical Data Review

Internal Validation Cohort

This cohort includes 188 clinical cases sourced from the SMART-CHD Study at Fuwai Hospital. These records serve as the primary internal benchmark to evaluate the diagnostic and extraction accuracy of the LLM workflow against the established ground truth.

Device: OCR-Prompt-LLM Information Extraction WorkflowDevice: Manual Clinical Data Review

External Validation Cohort

This cohort comprises 70 patient records collected from 8 independent sub-centers (excluding Fuwai Hospital) to assess the generalizability and robustness of the model across diverse clinical environments and different medical record formats.

Device: OCR-Prompt-LLM Information Extraction WorkflowDevice: Manual Clinical Data Review

Interventions

The intervention is an automated clinical data management system integrating Optical Character Recognition (OCR), optimized Prompt Engineering, and Large Language Models (LLMs). The workflow processes unstructured inpatient records to extract 10 key clinical indicators (e.g., LVEF, CAD subtypes, medications) and classifies the patient into specific coronary artery disease categories (UA, STEMI, NSTEMI, CCS)

External Validation CohortInternal Validation CohortTest Cohort

Standard manual process where experienced clinical physicians collect and interpret patient information from medical records. This serves as the human benchmark for comparing diagnostic accuracy and operational efficiency.

External Validation CohortInternal Validation CohortTest Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

he study population consists of 308 patients diagnosed with various subtypes of coronary artery disease (CAD). The cohort is derived from two major clinical studies: the AIM-CHD study (for pilot testing and prompt optimization) and the SMART-CHD study (for internal validation), both conducted at Fuwai Hospital. Additionally, an external validation cohort is included, comprising patients from 8 independent clinical sub-centers across China to ensure geographical and institutional diversity. The population covers a spectrum of CAD presentations, including Unstable Angina (UA), STEMI, NSTEMI, and Chronic Coronary Syndrome (CCS), providing a robust dataset for evaluating AI-driven diagnostic and data extraction performance.

You may qualify if:

  • Patients aged 18 years and older.
  • Clinical records of patients who were previously enrolled in the AIM-CHD (for the pilot/prompt optimization set) or SMART-CHD (for the internal validation cohort) studies.
  • Patients diagnosed with, or suspected of having, coronary artery disease (CAD), including subtypes: Unstable Angina (UA), STEMI, NSTEMI, and Chronic Coronary Syndrome (CCS).

You may not qualify if:

  • Clinical records with severe data fragmentation or missing more than 50% of the key clinical indicators.
  • Handwritten medical records or low-quality scans that are illegible for Optical Character Recognition (OCR) processing.
  • Duplicate records or records with conflicting "Gold Standard" labels that cannot be reconciled by the expert committee.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital

Beijing, 100037, China

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

February 23, 2026

Primary Completion

March 1, 2026

Study Completion

March 2, 2026

Last Updated

March 30, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

To protect patient privacy and comply with the data management policies of the participating institutions (Fuwai Hospital and sub-centers), individual participant data will not be made publicly available. However, aggregated study results and statistical analyses will be included in the final publication.

Locations